Supporting Clinical Trials Dr. Frank Wissing (DFG)
|
|
- Amanda Todd
- 7 years ago
- Views:
Transcription
1 Supporting Clinical Trials Dr. Frank Wissing (DFG)
2 Topics Who is the DFG? IITs in Germany Funding of Clinical Trials by the DFG (and others) Outlook
3 The DFG s mission Statement The DFG in a nutshell serves all branches of science and the humanities fosters scientific excellence through competition (peer review) supports international cooperation in research owned by scientists run by scientists Portfolio of flexible funding instruments Funding in 2012, by scientific discipline Engineering Sciences million (21.5%) Natural Sciences million (24.4%) Humanities and Social Sciences million (15.5%) Life Sciences million (38.6%)
4 Amount of research funding* awarded by research area for each calendar year 2009 to 2012 Biology Medicine Argriculture, Forestry, Horticulture and Veterinary Medicine * Funding amounts refer to both new and ongoing projects in the individual grants and coordinated programmes that receive funding in the year shown.
5 Topics Who is the DFG? IITs in Germany Funding of Clinical Trials by the DFG (and others) Outlook
6 Situation in Germany Health System: - ~ 200 Health Insurance Companies - health care providers fragmented Research System: - Separation between project funding and institutional funding - Separation between Länder- and central funding - Separation between basic research and applied research - Only universities with full research spectrum, but lacking core funding Regulatory System: - Many regulatory bodies on Länder -level - About 60 independent ethics committees - 4 central regulatory bodies (Bfarm, PEI, RKI, BfS)
7 Why we need Confirmatory Clinical Trials? Stakeholders Knowledge Use Patient Clinical Scientific Industry Societal Efficacy Effectiv eness Safety Marketing Approval RCT Costs Clinical Guidelines Disease Mechanisms Clinical Research
8 Why we need Confirmatory Clinical Trials? Stakeholders Knowledge Use Patient Clinical Scientific Industry Societal Efficacy Effectiv eness Safety Marketing Approval RCT Costs Clinical Guidelines Disease Mechanisms Clinical Research
9 Why we need Confirmatory Clinical Trials? Stakeholders Knowledge Use Patient Clinical Scientific Industry Societal Efficacy Effectiv eness Safety Marketing Approval RCT Costs Clinical Guidelines Disease Mechanisms Clinical Research
10 Who funds confirmatory IITs in Germany Industry German Research Foundation (DFG) Ministry for Research and Education (BMBF) University Core Funding Private Foundations EU Helmholtz Association Health Insurers Max-Planck-Association Fraunhofer Association Leibniz Association Ministry of Health (BMG) J J J J J J J J J J (J ) (J ) L L L L
11 Topics Who is the DFG? IITs in Germany Funding of Clinical Trials by the DFG (and others) Outlook
12 Clinical Trials Biomedical Research basic disease oriented patient oriented Interventional Clinical Studies exploratory confirmatory other: observational, epidemiological, genetic, public health etc.
13 Funding exploratory studies by the DFG Exploratory or observational studies on humans (e.g. early phase, translational, epidemiological, noninterventional) Funding via the regular project funding, e.g. individual grants coordinated funding programmes fellowships junior research groups estimated Mio Euro p.a. DFG funding
14 Observations for IITs in Germany Often study quality in comparison to the international standards too low Too few studies are being performed and published Low acceptance in medical faculties High manpower needed Too few young clinical investigators
15 Specific Problem: Funding for large, confirmatory clinical trials often limited Few funding options for non-industry funded trials 2003: Specific Funding instrument Goal: Long-term improvement of clinical trial quality and increase of acceptance of clinical studies in the scientific community and public
16 Which types of trials are eligible in the programme? confirmatory prospective multicentre clinical trials with patients a) controlled interventional therapeutical trials b) diagnostic studies (Phases II-IV according to Sackett) c) controlled interventional trials on secondary prevention d) prognostic studies e) systematic reviews (BMBF) Not: Trials where companies have direct commercial interest in the results
17 Main Criteria for the Peer Review Identification of the most excellent and most important trials by asking: " Is the clinical impact high? Will the trial make a powerful difference in patient care in the immediate future? " Is the trial internationally competitive? " Is the trial feasible? " Is the trial methodology sound? " No bonus for any discipline, only quality counts Peter Fonagy, London
18 Calls and Proposals (DFG+BMBF, ) 1. Call 2. Call 3. Call 4. Call 5. Call 6. Call 7. Call 8. Call Total Budget 10 Mio 20 Mio 20 Mio 30 Mio 30 Mio 30 Mio 30 Mio 30 Mio Outlines reviewed Invited Proposals (+4) 54(+3) funded trials 17 (41%) 18 (58%) 21 (51%) 23 (35%) 16 (28%) 20 (34%) 14 (30%) 18 (44%) rejected 24 (59%) 13 (42%) 20 (49%) 42 (65%) 41 (72%) 39 (66%) 33 (70%) 23 (56%)
19 Clinical Trials: Areas of proposals Numbers of outlines and proposals submitted and funded Outlines Full Proposals Funded Proposals
20 Some numbers Example 7. Call 2011 Min Max Average Patients/Trial Centers/Trial Management ( /a) Monitoring ( /Patient/ Center) Casepayments ( / Patient) Medication ( /Patient) Insurance ( /Patient) Patient Budget ( /Patient) Total Budget ( ) (47 Full proposals; DFG-proposals only year 1-3; Patients N total = ; Centers N total = 612
21 Support by KKS and CRO Survey March N Yes, KKS Yes, CRO No Other ja, KKS ja, CRO nein Sonstige 21
22 Example: KKS in the 5th Call Ca. 200 submitted outlines (DFG und BMBF) Of these 62 with search word KKS or ZKS (DFG und BMBF) 37 full proposals at DFG Of these 24 with KKS support 11 funded proposals at the DFG Of these 9 with KKS support
23 Delayed Recruitment 16 Status current Recruitmentphase (2011) (n=51) N >160 Current recruitment in relation to plan (March 2011) Currently under plan Currently above plan
24 Results of DFG-funded trials (Started ) 74 trials funded 9 with final report (May 2014) 7 with final publication (average 6 publications/trial) Results published in (British J Psychiatry, NEJM, Epidemiology and Psychiatric Sciences, Eur Psychiatry, Behav Brain Res., Arch Int Med., Ann Rheum Dis., 2 in preperation) 10 stopped/never started
25 Accompanying Measures: Examples Infrastructures: 12 Coordinating Centres for Clinical Trials (since 1998) 6 Study Centres (since 2006) National Trial Register (WHO, since 2008) Centres for Translational Health Research (Cancer, Diabetes, Heart, Lung, Infection, Neuro) Research Networks/Consortia 40 Clinical Research Units Competence Networks in Medicine Cancer Trials / Compr. Cancer Centres Training Junior Training Academy Clinical Trials
26 Funding Clinical Trials since 2013 Regular Programme, open topic 2 stages; standing scientifc committee; up to 15 Mio p.a. Annual Calls, as yet open topic 2 stages, stage 1: Relevance Board; stage 2: Scientific Board; up to 15 Mio p.a. Topics initiated by Federal Joint Committee (G-BA) or suggested by applicants/companies; Study design by G-BA, advertised, study group selected by G-BA
27 Topics Who is the DFG? IITs in Germany Funding of Clinical Trials by the DFG (and others) Outlook
28 Outlook Further Challenges and Solutions High economic pressure on university clinics/less time for research High costs due to high regulatory burden adequate budget planning and funding risk adapted approach (insurances, fees, monitoring, safety)? Trials with high socio-economic relevance / low scientific interest prioritising and funding by health insurers / health politics? Funding for multinational trials Lead Agency procedures by national funders? Joint agreements? European wide funding via EU?
29 Thank you very much for your attention! Frank Wissing German Research Foundation (DFG) Further information
International Degree Programs
Study & Research in Germany International Degree Programs Many German universities offer courses leading to an international degree. The more than 400 courses presented in this category are designed to
More informationBIMA81, Biomedicine: Molecular Medicine, 15 credits Biomedicin: Molekylär medicin, 15 högskolepoäng First Cycle / Grundnivå
Faculty of Medicine BIMA81, Biomedicine: Molecular Medicine, 15 credits Biomedicin: Molekylär medicin, 15 högskolepoäng First Cycle / Grundnivå Details of approval The syllabus was approved by Committee
More informationResearch Design Service London
Research Design Service London Enabling Better Research Peter Lovell Programme Manager 27 th October 2011 Overview of presentation An introduction to the NIHR Research Design Service (RDS) Outline of the
More informationA Closer Look at Stem Cell Treatments An ISSCR Initiative
A Closer Look at Stem Cell Treatments An ISSCR Initiative Heather Rooke IASCR, Washington, DC USA, October 19-20, 2010 Commercialized Stem Cell Treatments on the Web Exploitation of the much-cited promise
More informationSheffield Kidney Institute. Planning a Clinical Trial
Planning a Clinical Trial Clinical Trials Testing a new drug Ethical Issues Liability and Indemnity Trial Design Trial Protocol Statistical analysis Clinical Trials Phase I: Phase II: Phase III: Phase
More informationEU Clinical Trials Register. www.clinicaltrialsregister.eu. An agency of the European Union
EU Clinical Trials Register www.clinicaltrialsregister.eu An agency of the European Union The EU Clinical Trials Register provides public access to information from the European Union (EU) clinical trial
More informationBIH BIOMEDICAL ACADEMY FUNDING OPPORTUNITIES
BIH BIOMEDICAL ACADEMY FUNDING OPPORTUNITIES AT A GLANCE The Berlin Institute of Health (BIH) is a new biomedical research institute focusing on trans lational research. The institute s scientific leitmotiv
More informationTranslational research infrastructure in Neurosciences 15.06.2011/Bruxelles
ITMO Neurosciences, sciences cognitives, neurologie, psychiatrie Translational research infrastructure in Neurosciences 15.06.2011/Bruxelles ITMO Technologie pour la santé 1 NEUROSCIENCE MEDICAL CHALLENGES
More informationBuilding Links to Academic Research in Germany
Deutsche Forschungsgemeinschaft German Research Foundation English Building Links to Academic Research in Germany Funding Opportunities for International Cooperation About Us Funding International Research
More informationKatrin Eichelberg, PhD
Katrin Eichelberg, PhD Office of Research Training and Special Programs Division of Extramural Activities, NIAID, NIH keichelberg@niaid.nih.gov June 7 th, 2013 Welcome to Bethesda! NIH 27 Institutes and
More informationPriority Program Translational Oncology Applicants' Guidelines
Stiftung Deutsche Krebshilfe Dr. h.c. Fritz Pleitgen Präsident Spendenkonto Kreissparkasse Köln IBAN DE65 3705 0299 0000 9191 91 BIC COKSDE33XXX Priority Program Translational Oncology Applicants' Guidelines
More informationUniversity Medical Centres
University Medical Centres in the Netherlands AMC UMC Utrecht University Medical Centres University Medical Centres and the Health System Reform in the Netherlands: a Position Paper In the last ten years
More informationSponsoring concept. International MD/PhD Program Molecular Medicine. Hannover Medical School, Germany. Content. I. Mission and Aims 2
Sponsoring concept International MD/PhD Program Molecular Medicine Hannover Medical School, Germany Content I. Mission and Aims 2 1. Mission 2 2. Global Aims 2 3. Strategic Aims 2 II. Sponsoring concept
More informationThe Department of Public Health Sciences
The Department of Public Health Sciences Who we are at the U.Va. School of Medicine Committed to improving population health and clinical care The Department of Public Health Sciences, established in 1995,
More informationRoche Position on Human Stem Cells
Roche Position on Human Stem Cells Background Stem cells and treating diseases. Stem cells and their applications offer an enormous potential for the treatment and even the cure of diseases, along with
More informationTelemedicine in the Prevention and Monitoring of Heart Disease
Telemedicine in the Prevention and Monitoring of Heart Disease Prof. Dr. med. Friedrich Köhler 26. April 2012 Charité-Universitätsmedizin Berlin Facts Founded in 1710 11 Nobel laureates 12.922 employees
More informationNIHR Research Design Service London Dr Peter Lovell Deputy Director
NIHR Research Design Service London Dr Peter Lovell Deputy Director Research Design Service (RDS) A national network of support services; Supporting those who are putting together REGIONAL RDS North East
More informationCLINICAL RESEARCH NETWORK
CLINICAL RESEARCH NETWORK Introduction The vision of the National Institute for Health Research (NIHR) is to improve the health and wealth of the nation through research. This document sets out how the
More informationHow To Understand The Relationship Between Genetics And Environment
Different Pathomechanisms for Asthma and Allergies (NEJM 363:121ff) Genetics of Complex Diseases Unraveled by Combining GWAS and Metabolomics (Nature Genetics 42:137. PLoS Genetics 4:1) Disease Management
More informationGraduate School of Excellence Exzellenz-Graduiertenschule
Jena School for Microbial Communication Graduate School of Excellence Exzellenz-Graduiertenschule Microbial Communication Talking Microbes? Microorganisms are present everywhere. They are often considered
More informationResearch & Funding Opportunities in Germany. Dr. Alexandra Gerstner DAAD Information Centre Toronto
Research & Funding Opportunities in Germany Dr. Alexandra Gerstner DAAD Information Centre Toronto Memorial University February 9 th, 2015 German Funding Programmes for Scientists & Researchers 1. The
More informationResearch for a Healthy Life RESEARCH
Research into Prevention and Nutrition - Action Plan Research for a Healthy Life RESEARCH Research into Prevention and Nutrition - Action Plan Research for a Healthy Life RESEARCH Contents 1 Contents
More informationUse advanced techniques for summary and visualization of complex data for exploratory analysis and presentation.
MS Biostatistics MS Biostatistics Competencies Study Development: Work collaboratively with biomedical or public health researchers and PhD biostatisticians, as necessary, to provide biostatistical expertise
More informationThe Blood Donor BIOBANK
The Blood Donor BIOBANK the first successful combination of blood donation and biobanking for medical research 1 1 Zoglmeier et al., TRANSFUSION 2011, 51(5): 1121-1122 Dr. Franz Weinauer SWISSTRANSFUSION
More informationCurrent reporting in published research
Current reporting in published research Doug Altman Centre for Statistics in Medicine, Oxford, UK and EQUATOR Network Research article A published research article is a permanent record that will be used
More informationKnowledge Management Policy
Knowledge Management Policy Knowledge Management (KM) envisages capturing, creating, sharing and managing knowledge. KM comprises of three components (i) people who create, share and use knowledge as part
More informationHow does the SNSF support careers in research? Marcel Kullin, November 2011
How does the SNSF support careers in research? Marcel Kullin, November 2011 Summary 1. SNSF in brief 2. Funding opportunities for young researchers Funding chain Funding Instruments Success rates 3. Outlook
More informationResearch Agenda for General Practice / Family Medicine and Primary Health Care in Europe Summary EGPRN
Research Agenda for General Practice / Family Medicine and Primary Health Care in Europe Summary EGPRN EUROPEAN GENERAL PRACTICE RESEARCH NETWO RK EGPRN is a network organisation within WONCA Region Europe
More informationWhat does the AHSC mean for you?
> > > > > > > > > > > > > > > > > > > > What does the AHSC mean for you? Our vision for the UK s first Academic Health Science Centre a mini-guide for patients Quicker access to new medicines and new treatments
More informationNational Health Research Policy
National Health Research Policy The establishment of a Department of Health Research (DHR) in the Ministry of Health is recognition by the GOI of the key role that health research should play in the nation.
More informationERA-Net COFUND Research Programmes on Rare Diseases (E-RARE)
Bologna 15 Dicembre 2014 ERA-Net COFUND Research Programmes on Rare Diseases (E-RARE) The Role of RER-ASSR Antonio Addis Research Governance Area Agenzia Sanitaria e Sociale Regionale How do Regions might
More informationOctober 17, 2005. Elias Zerhouni, M.D. Director National Institutes of Health One Center Drive Suite 126 MSC 0148 Bethesda, MD 20892
October 17, 2005 Elias Zerhouni, M.D. Director National Institutes of Health One Center Drive Suite 126 MSC 0148 Bethesda, MD 20892 Dear Dr. Zerhouni: The undersigned nonprofit medical and scientific societies
More informationPostdoctoral Researchers International Mobility Experience (P.R.I.M.E.) 2015
Postdoctoral Researchers International Mobility Experience (P.R.I.M.E.) 2015 Objective With this new programme and funding from the Federal Ministry of Education and Research (BMBF) and the European Union
More informationJSA in Germany with BfArM/PEI and G-BA
JSA in Germany with BfArM/PEI and G-BA 16 th DGRA Annual Congress Bonn, 8 May 2014 Thomas Mueller Head of Pharmaceuticals Department Federal Joint Committee (GBA) Seite 3 2014 Thomas Müller AMNOG in brief
More informationTHE LINCOLN INSTITUTE OF HEALTH
THE LINCOLN INSTITUTE OF HEALTH Background The Chair in the Care of the Older Person will be part of the new Lincoln Institute of Health, a cross disciplinary research collaboration linking schools, colleges
More informationWhat We Are..! www.ardent-cro.com
Your Trusted CRO! Regus, Level-2, Connaught Place, Bund Garden Road, Pune-411001, MH, India. Phone: 020-65-31-31-71 Email: ardent@ardent-cro.com Web: What We Are..! Ardent Clinical Research Services is
More informationECRIN General Presentation
ECRIN General Presentation Supporting Clinical Trials Across Borders Gonzalo Calvo 26-01-16 ECRIN Overview A non-profit organisation with the legal status of European Research Infrastructure Consortium
More informationThe University of Edinburgh Global Health Academy
The University of Edinburgh Global Health Academy Collective Vision for Global Health Academy Bringing together the University s eminent Global Health Scientists and Practitioners and students from disciplines
More informationLocation for Trials- Global Considerations A Pharma Perspective. Carlo Maccarrone Assoc. Director, Clinical Research GSK Australia 7 May 2014
Location for Trials- Global Considerations A Pharma Perspective Carlo Maccarrone Assoc. Director, Clinical Research GSK Australia 7 May 2014 Why Choose Australia for Clinical Trials? What is he saying
More informationClinical trials: The EU perspective. Dr Karim Berkouk, Deputy Head of Unit DG for Research and Innovation Health Directorate European Commission
Clinical trials: The EU perspective Dr Karim Berkouk, Deputy Head of Unit DG for Research and Innovation Health Directorate European Commission Content 1.EU: The global picture 2.EU & Clinial trials: The
More informationFunding Programmes for Scientists and Researchers in Taiwan
Funding Programmes for Scientists and Researchers in Taiwan Ausserh of e r/ Hims e l/ DAA D Hag eng ut h/ DAA D Forschungsverbund Berlin B e z e r g h e a n u M ir c e a Syngenta Hub/DAA D Sanofi-aventis
More informationBSc (Hons)/MSc Nutritional Sciences - SC527 (Under Review)
BSc (Hons)/MSc Nutritional Sciences - SC527 (Under Review) Specific Titles: BSc (Hons) /MSc Nutritional Sciences BSc (Hons) Nutritional Sciences (Specialisation: Dietetics) 1. Rationale and Objectives
More informationREGULATIONS FOR THE POSTGRADUATE DIPLOMA IN PSYCHO-ONCOLOGY (PDipPsycho-oncology)
535 REGULATIONS FOR THE POSTGRADUATE DIPLOMA IN PSYCHO-ONCOLOGY (PDipPsycho-oncology) (See also General Regulations) M.105 Admission requirements To be eligible for admission to the programme leading to
More informationCompetencies for the nurse practitioner scope of practice
Competencies for the nurse practitioner scope of practice Approved by Council September 2008 Nurse practitioner scope of practice Nurse practitioners are expert nurses who work within a specific area of
More informationFINLAND ON A ROAD TOWARDS A MODERN LEGAL BIOBANKING INFRASTRUCTURE
Postrefereed, preprint version of the text published at European Journal of Health Law 2013(3)28994. Link to the publisher s website: http://www.brill.com/europeanjournalhealthlaw Sirpa Soini FINLAND ON
More informationResearch. Evidence. Our mission: and to improve healthcare delivery. Delivering future health
Research. Our mission: Evidence. to improve Action. people s HRB Strategy health 2016-2020 and to improve healthcare delivery Delivering future health HRB Strategy 2016-2020 We will lead and support excellent
More informationDiscovery Grants. 2015-2016 Request for Applications
The mission of the American Brain Tumor Association is to advance the understanding and treatment of brain tumors with the goals of improving, extending and, ultimately, saving the lives of those impacted
More informationKey considerations for outsourcing late phase clinical research
Key considerations for outsourcing late phase clinical research Alan Nelson (on behalf of Van Zyl Engelbrecht) Senior Project Director at UBC: An Express Script Company Layout of presentation My presentation
More informationBackground and purpose of the meeting International Workshop on Methods for Health Economic Evaluations of Vaccines Berlin, May 12-13 2014
Background and purpose of the meeting International Workshop on Methods for Health Economic Evaluations of Vaccines Berlin, May 12-13 2014 Ole Wichmann, MD Immunization Unit Vaccine introduction decisions
More informationGUIDELINES for BIH translational Ph.D. grants
GUIDELINES for BIH translational Ph.D. grants The BIH aims at training a new generation of translational scientists and will establish different interlinked training programs. This includes funding of
More informationStarting your research career - DFG funding programmes and application procedures
Starting your research career - DFG funding programmes and application procedures Topics 1. What is, what does the DFG? 2. The DFG Funding Portfolio 3. Application and review procedures What is the DFG?
More informationThe new European clinical trials regulation Dr. N.Gökbuget
The new European clinical trials regulation Dr. N.Gökbuget Head of Study Center Department of Medicine II and Goethe University Cancer Center Frankfurt, Germany European Leukemia Net: Major Aim to Foster
More informationThe National Institute of Genomic Medicine (INMEGEN) was
Genome is...... the complete set of genetic information contained within all of the chromosomes of an organism. It defines the particular phenotype of an individual. What is Genomics? The study of the
More informationTechnical Writing - Project Integration in Germany
LpSys: Preparation of new project Integration in current project, reference number Title of proposal (in English): Title of proposal (in German): Duration: Start End German partner (Principal investigator)
More informationTUFTS UNIVERSITY SCHOOL OF MEDICINE Institutional Educational Objectives
1 TUFTS UNIVERSITY SCHOOL OF MEDICINE Institutional Educational Objectives The central aim of the School of Medicine is to produce highly competent, intellectually curious and caring physicians. To this
More informationMedical Education in the United States, in the United Kingdom and in Japan. Nayuta Saito. The Jikei University School of Medicine. Anes 140.
Medical Education in the United States, in the United Kingdom and in Japan Nayuta Saito The Jikei University School of Medicine Anes 140.01 Rotation: June 9 - July 3, 2008 I am a medical student in Tokyo,
More informationQuality assurance of doctoral education in an interfacultary Graduate School
Quality assurance of doctoral education in an interfacultary Graduate School Utrecht University Graduate school of Life Sciences Utrecht, The Netherlands Saskia Ebeling PhD Administrative Secretary to
More information1) SCOPE OF THE PROGRAM
CALL FOR PROJECTS 2015/16 CANADA/GERMANY JOINT PROGRAM DEADLINE: 15 TH JANUARY 2016 1) SCOPE OF THE PROGRAM The main goal of the Canada/Germany joint program is to strengthen research in Canada and Germany
More informationQUESTIONS FOR The Commonwealth Medical College
Page 1 QUESTIONS FOR The Commonwealth Medical College PROCESS OF CURRICULUM REDESIGN Why did you redesign your curriculum? What were your goals? What was the timeframe? What lessons were learned while
More informationExascale seen from a DFG perspective
Exascale seen from a DFG perspective DFG The German Research Foundation Marcus Wilms What is the DFG? An association under German private law The DFG research universities, non-university research institutions,
More informationNOTE COST Committee of Senior Officials (CSO) COST Strategy towards increased support of early stage researchers
European Cooperation in the field of Scientific and Technical Research - COST - Secretariat ------- Brussels, 4 December 2009 COST 295/09 NOTE To : Subject : COST Committee of Senior Officials (CSO) COST
More informationNurse Practitioner Mentor Guideline NPAC-NZ
Nurse Practitioner Mentor Guideline NPAC-NZ Purpose To provide a framework for the mentorship of registered nurses to prepare for Nurse Practitioner (NP) registration from the Nursing Council of New Zealand.
More informationIl ruolo dell Advisory Group for «Health, Wellbeing and Demographic Change» in Horizon 2020
Il ruolo dell Advisory Group for «Health, Wellbeing and Demographic Change» in Horizon 2020 Lucia Monaco Horizon 2020 Advisory Group, Societal Challenges 1: Health, Demographic Change and Wellbeing Seminario:
More informationObtaining Funding in Clinical Research
Obtaining Funding in Clinical Research Ellen Seely, MD Director of Clinical Research Endocrinology, Diabetes and Hypertension Division Vice Chair, Faculty Development, Department of Medicine Brigham and
More informationOverview on Research Careers in Germany
Overview on Research Careers in Germany The German Academic System Institutions of Research and Higher Education in Germany Institutions of higher learning in Germany, among them: universities several
More informationREGIONAL GUIDELINES FOR ASSESSMENT AND RECOGNITION OF MEDICAL SCHOOLS
REGIONAL GUIDELINES FOR ASSESSMENT AND RECOGNITION OF MEDICAL SCHOOLS INTRODUCTION: The guidelines were developed by Medical Regulatory Boards and Councils following a directive by the 3 rd EAC Sectoral
More informationGood Scientific Practice
Section 1: The purpose of this document There are three key components to the Healthcare Science workforce in the UK: 1. Healthcare Science Associates and Assistants who perform a diverse range of task
More informationRegistries: An alternative for clinical trials?
Registries: An alternative for clinical trials? Prof. Dr. Joerg Hasford, M.D., Ph.D. Department of Medical Informatics, Biometry and Epidemiology Ludwig-Maximilians-Universität Email: has@ibe.med.uni-muenchen.de
More informationOffice of Clinical Research and the. Institute (CTSI) Patricia Emmanuel, MD
Office of Clinical Research and the Clinical and Translational Research Institute (CTSI) Patricia Emmanuel, MD Office of Clinical Research- Priorities Review processes for clinical study implementation,
More informationTransCelerate's Role in Transforming Pharmaceutical Trials Presentation to PCORNet
TransCelerate's Role in Transforming Pharmaceutical Trials Presentation to PCORNet Dalvir Gill, PhD - Chief Executive Officer 17 October, 2014 Presentation Objectives + TransCelerate History + Participating
More informationKnowledge Management policy for Health - Service, Education and Research
Knowledge Management policy for Health - Service, Education and Research (Final Draft Document) 1 Knowledge Management policy for Health - Service, Education and Research Department of Health Research
More informationPostdoctoral Researchers International Mobility Experience (P.R.I.M.E.)
Postdoctoral Researchers International Mobility Experience (P.R.I.M.E.) Objective With this new programme and funding from the Federal Ministry of Education and Research (BMBF) and the European Union 1
More informationAnn-Lise Guisset agu@euro.who.int Division of Health Systems and Public Health World Health organization Regional Office for Europe
Ann-Lise Guisset agu@euro.who.int Division of Health Systems and Public Health World Health organization Regional Office for Europe Understands health and disease Measuring health status, carrying out
More informationBlood Biobanking Chances and Risks. The Bavarian Red Cross Blood Donor Biobank
Blood Biobanking Chances and Risks The Bavarian Red Cross Blood Donor Biobank EORTC-NCI-ASCO Meeting - November 2007 Outline Types of biobanking Why blood biobanking? Why blood banks? Why the Bavarian
More informationTO THE JOINT TRANSNATIONAL CALL 2015 FOR EPIGENOMICS OF COMPLEX DISEASES
CALL TEXT TO THE JOINT TRANSNATIONAL CALL 2015 FOR EPIGENOMICS OF COMPLEX DISEASES Submission deadline of proposals: 30 th of January 2015 at 01 p.m. CET (Paris, Berlin local time) Link to Call for Proposals
More informationScientific Data Management in Large University Research Projects. A Status Report
Scientific Data Management in Large University Research Projects. A Status Report Scientific Research Date in Germany, DFG Workshop Eva Effertz; Washington DC, 2011-06-21 DFG promotes scientific infrastructure
More informationOxford, Innovations in Biomedical Research
Oxford, Innovations in Biomedical Research Tomas Farchi Said Business School University of Oxford Conference: "The French Contribution in a World of Innovation" Maison Française d Oxford, 27th and 28th
More informationNew challenges in public health education and training in the Slovak Republic
New challenges in public health education and training in the Slovak Republic Gabriel Gulis 1, Zuzana Katreniakova 2, Jana Kollarova 2,3 1 University of Southern Denmark, Unit for Health Promotion Research,
More informationSPACE-2 Why was the protocol modification not successful? Peter A. Ringleb Department of Neurology
SPACE-2 Why was the protocol modification not successful? Peter A. Ringleb Department of Neurology Disclosures Peter A. Ringleb, MD Professor of Vascular Neurology and head of the Stroke service at the
More informationClinical research trials and insurance
Clinical research trials and insurance Information for people who are planning to take part in a clinical research trial January 2011 This information is subject to change depending on medical advances
More informationFiscal Year 2013 (FY13) Prostate Cancer Research Program (PCRP) Reference Table of Award Mechanisms and Submission Requirements
Fiscal Year 2013 (FY13) Prostate Cancer Research Program (PCRP) Reference Table of Award Mechanisms and Submission Requirements PCRP AWARD MECHANISMS WITH EMPHASIS ON RESOURCES Clinical Consortium Award
More informationRestructuring the Federal Governmental Research in Agriculture and Food in Germany
Restructuring the Federal Governmental Research in Agriculture and Food in Germany Foulum,, 19. September 2008 Dr. Christian Patermann Former Director Biotechnologies, Agriculture and Food DG Research,
More informationCOMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP)
London, 22 October 2009 Doc. Ref. EMEA/CHMP/EWP/692702/2008 COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) REFLECTION PAPER ON THE EXTRAPOLATION OF RESULTS FROM CLINICAL STUDIES CONDUCTED OUTSIDE
More information2019 Healthcare That Works for All
2019 Healthcare That Works for All This paper is one of a series describing what a decade of successful change in healthcare could look like in 2019. Each paper focuses on one aspect of healthcare. To
More informationHealthcare Coalition on Data Protection
Healthcare Coalition on Data Protection Recommendations and joint statement supporting citizens interests in the benefits of data driven healthcare in a secure environment Representing leading actors in
More informationFederal Ministry of Education and Research
Federal Ministry of Education and Research Announcement Regulations for funding of products for the prevention, diagnosis and treatment of neglected and poverty-related diseases 1 Funding purpose Poor
More informationRESEARCH TRAINING & CAREER DEVELOPMENT
RESEARCH TRAINING & CAREER DEVELOPMENT Introduction The vision of the National Institute for Health Research (NIHR) is to improve the health and wealth of the nation through research. This document sets
More informationSyllabus - Master Programme in Global Health
Ref 4295/2007-350 Syllabus - Master Programme in Global Health 3GB08 Established by the Board of Higher Education, 7 November 2007 Confirmed by the Board of Higher Education, 28 November 2007 Sid 2 (5)
More informationClinician Investigator Program
Clinician Investigator Program Queen s Clinician Investigator Program: Developing the next Overview The Queen s University Clinician Investigator Program (CIP) is an intensive, research-based postgraduate
More informationMasters Learning mode (Форма обучения)
Program Title (Название программы): Pharmacology Degree (Степень) Masters Learning mode (Форма обучения) Full-time and part-time Duration of study (Продолжительность программы) 2 years (4 years part time)
More informationNURSE PRACTITIONER CORE COMPETENCIES April 2011
NURSE PRACTITIONER CORE COMPETENCIES April 2011 Task Force Members Anne C. Thomas, PhD, ANP-BC, GNP - Chair M. Katherine Crabtree, DNSc, FAAN, APRN-BC Kathleen R. Delaney, PhD, PMH-NP Mary Anne Dumas,
More informationMRes Science Project Titles 2015/16 School of Health Sciences and Social Work, University of Portsmouth
MRes Science Project Titles 2015/16 School of Health Sciences and Social Work, University of Portsmouth The Master of Research (MRes) Science course is a postgraduate course that will provide applicants
More informationHealthcare Science Programme Guide
Healthcare Science Programme Guide BSc. (HONS) Healthcare Science (Life Sciences) BSc. (HONS) Healthcare Science (Physiological Sciences) This guide has been compiled to give an overview of the Healthcare
More informationThe Johann Heinrich von Thünen Institute research in the fields of Rural Areas, Forestry, and Fischeries
Institut für The Johann Heinrich von Thünen Institute research in the fields of Rural Areas, Forestry, and Fischeries Walter Seidling (Eberswalde) and Stefan Lange (Braunschweig) E-URAL workshop on Nature
More informationCALL FOR APPLICATIONS
CALL FOR APPLICATIONS WHO/TDR International Postdoctoral Training Scheme at the Noguchi Memorial Institute for Medical Research University of Ghana, Legon-Accra Deadline for submission: 28 February 2016
More information2013-04-16 to 2013-04-19. Hanno Langweg, Einar Snekkenes (HiG)
COINS study tour 2013-04-16 to 2013-04-19. Hanno Langweg, Einar Snekkenes (HiG) Seven institutions were selected to collect their experience with Ph.D. training in security and computer science. The selection
More informationThe Research Capability Programme. Peter Knight, Group Programme Director
The Research Capability Programme Peter Knight, Group Programme Director 11/03/2010 RESEARCH FOR PATIENT BENEFIT WORKING PARTY FINAL REPORT For us, science and research constitute a front-line service,
More informationDIRECTOR, POPULATION HEALTH SCIENCES INITIATIVE
! DIRECTOR, POPULATION HEALTH SCIENCES INITIATIVE Southern Illinois University School of Medicine in Springfield, IL, invites applicants for the position of Associate Professor or Professor and Director
More informationBrief intervention in a general hospital for problematic prescription drug use: Outcome at 3- and 12-month follow-up
Brief intervention in a general hospital for problematic prescription drug use: Outcome at 3- and 12-month follow-up Gallus Bischof, Anne Zahradnik, Christiane Otto, Brit Crackau, Ira Löhrmann, Ulrich
More informationBOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH PUBLIC HEALTH COMPETENCIES
BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH PUBLIC HEALTH COMPETENCIES Competency-based education focuses on what students need to know and be able to do in varying and complex situations. These competencies
More information